Spica Therapeutics is developing novel, pathogenic macrophage subset-targeted therapeutics to address the unmet needs of patients across multiple disease areas including oncology, fibrosis and autoimmune disease.
Employees
11-50This company has no org chart yet
This company has no teams yet
This company has no offices yet